Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates
March 28, 2025
Technology
-
-
Upcoming Aditxt Weekly Update to Highlight Pearsanta’s Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer Detection
March 28, 2025
-
Boardwalktech and Trillium Announce Partnership for Supply Chain Solutions
March 28, 2025
-
ZenaTech Signs LOI to Acquire Eighth Land Survey Company Advancing Drone as a Service in a $2.5 Billion US Drone Survey Market by 2033
March 27, 2025
-
WISeSat Prepares for June Launch of Its Second-Generation Satellite and Expands Global Footprint
March 27, 2025
-
Rimini Street Launches Rimini Manage(TM) for Workday
March 27, 2025
-
DatChat Launches Myseum Social Media Platform for Apple iOS and Android Platforms
March 25, 2025
-
High Wire Networks Secures New Deal with Leading MSP Location to Manage 1,100+ Endpoints
March 25, 2025
-
Plurilock and Forcepoint Partner to Strengthen Cybersecurity Solutions and Expand Market Reach
March 25, 2025
-
Aditxt Subsidiary Pearsanta Completes the Acquisition of Proprietary Adductomics Technology to Develop and Advance the Platform Toward Clinical and Commercial Applications for Monitoring Early Signs of Increased Cancer Risk
March 24, 2025
-
PharmAla Contracts with Partner to Act as US Distributor
March 24, 2025
-
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
March 24, 2025
-
AI Becoming Essential to HCM, ISG Says
March 21, 2025
-
Kaltura Announces Stock Repurchase Program
March 21, 2025
-
Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million
March 21, 2025
-
Research Solutions Launches Advanced Reasoning AI Model Optimized For Scientific Research
March 20, 2025